Avecho Biotechnology Limited (AVEFF)
OTCMKTS · Delayed Price · Currency is USD
0.0045
-0.0129 (-74.14%)
At close: May 2, 2025
Avecho Biotechnology Revenue
Avecho Biotechnology had revenue of 560.07K AUD in the half year ending June 30, 2025, with 25.45% growth. This brings the company's revenue in the last twelve months to 1.38M, up 306.88% year-over-year. In the year 2024, Avecho Biotechnology had annual revenue of 1.13M with 139.19% growth.
Revenue (ttm)
1.38M AUD
Revenue Growth
+306.88%
P/S Ratio
28.79
Revenue / Employee
92.04K AUD
Employees
15
Market Cap
26.06M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.13M | 659.12K | 139.19% |
| Dec 31, 2023 | 473.55K | -655.71K | -58.07% |
| Dec 31, 2022 | 1.13M | 335.66K | 42.30% |
| Dec 31, 2021 | 793.60K | 408.97K | 106.33% |
| Dec 31, 2020 | 384.63K | -3.85M | -90.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zeo ScientifiX | 5.20M |
| Harvard Apparatus Regenerative Technology | 743.00K |
| Zenith Capital | 500.00K |
| Provectus Biopharmaceuticals | 350.44K |
| ZIVO Bioscience | 209.03K |
| Arch Biopartners | 198.11K |